Adaptimmune Therapeutics Free Cash Flow (Quarterly) Insights

Adaptimmune Therapeutics PLC (ADAP)

0.5868 0.00 (0.00%) USD | NASDAQ | Nov 15, 16:00

0.586 0.00 (0.00%) After-Hours: 16:55

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
June 30, 2024	46.64M
March 31, 2024	-32.31M
December 31, 2023	-15.50M
September 30, 2023	-45.45M
June 30, 2023	-45.00M
March 31, 2023	-39.80M
December 31, 2022	-1.386M
September 30, 2022	-58.40M
June 30, 2022	-50.21M
March 31, 2022	-61.52M
December 31, 2021	129.89M
September 30, 2021	-46.87M
June 30, 2021	-33.24M
March 31, 2021	-47.82M
December 31, 2020	-30.45M
September 30, 2020	-17.12M
June 30, 2020	-25.44M
March 31, 2020	16.51M
December 31, 2019	-13.14M

Date	Value
September 30, 2019	-29.94M
June 30, 2019	-35.18M
March 31, 2019	-37.31M
December 31, 2018	-31.90M
September 30, 2018	8.599M
June 30, 2018	-36.60M
March 31, 2018	-49.19M
December 31, 2017	-23.29M
September 30, 2017	11.86M
June 30, 2017	-26.97M
March 31, 2017	-40.93M
December 31, 2016	-4.551M
September 30, 2016	-17.46M
June 30, 2016	-17.70M
March 31, 2016	-21.25M
September 30, 2015	-7.128M
December 31, 2014	-3.422M
September 30, 2014	-13.62M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-61.52M

Minimum

Mar 2022

129.89M

Maximum

Dec 2021

-19.51M

Average

-32.31M

Median

Mar 2024

Free Cash Flow (Quarterly) Benchmarks